Service Description | Diverse hiPSC derived cell differentiation

NUOXINTE has high-performance 2D differentiation technology for heart, nerve, and liver cells, as well as 3D differentiation technology for organoids such as the heart, brain, liver, and skin.

Service Description | Cardiac Safety Assessment

NUOXINTE has multiple cardiac safety analysis platforms, including Agilnet, AXION, and Nanion, which can measure the electrophysiological signals and contractility of myocardial cells. Customers can freely choose analysis equipment and techniques according to their own purposes.

Service Description | Toxicity Testing

NUOXINTE provides high-throughput drug toxicity testing services based on 2D cells and 3D organoids as the basic platform.

Service Description | Efficacy Evaluation

NUOXINTE has multiple disease models in the heart, brain, and liver, including acute myocardial infarction, Parkinson's disease, autism, and non-alcoholic fatty liver disease. Provide high-throughput drug efficacy evaluation services based on disease model organoids.

Service Description | Design Your Own Service

By utilizing NUOXINTE's diverse 2D cell and 3D organoid platforms, as well as various detection equipment and technologies, design your own drug testing services to save time and costs, and accelerate the development of new drugs.

Step 1: Choose the model platform you need from NUOXINTE's 2D cell and 3D organoid products.

Step 2: Choose various functional toxicity and efficacy evaluation platforms of NUOXINTE, including cardiac safety evaluation (CiPA).

Step 3: Based on the characteristics of the candidate drug, freely choose the processing time, processing concentration, analysis equipment, and analysis method.